banner-field

Solutions

Macromolecule Drug Clinical Trials - Laboratory Solutions


Due to the complexity of tumor biology, tumor drug development is full of challenges. Compared with other diseases, Hematological malignancies require multi-omics platforms (M: morphology, I: immunology, C: cytogenetics, M: molecular biology, etc.) to provide necessary information for disease diagnosis, treatment, prognosis, etc., and rely on the services provided by the central laboratory.


KingMyLab has established a sound MICM and other multi-omics platforms, which can fully support the research of biomarkers related to Hematological malignancies drug development. At present, we have helped more than 300 clinical research projects of Hematological malignancies , involving small molecules, monoclonal antibody/double antibody and other macromolecules, CAR-T (chimeric antigen receptor T cell) and other therapies, covering diseases such as leukemia, lymphoma and multiple myeloma. 

Pharmacokinetics (PK) Study
Pharmacokinetics (PK) Study


Servies: Drug Concentration, Absorption, Distribution, Metabolism, Excretion, etc.

Platforms: LAB, etc.


Immunogenicity Analysis
Immunogenicity Analysis


Servies Anti-Drug Antibody, Neutralizing Antibody, etc.

Platforms: LBA, CBA, etc.


Disease Diagnosis  for Patient Inclusion and Exclusion
Disease Diagnosis for Patient Inclusion and Exclusion

ServiesBlood Smear, Bone Marrow Smear, Histopathology, Immune Typing, Karyotype and Chromosome Variation, Genetic Mutation or Rearrangement, Blood, Urine Tests, etc.

Platforms: Karyotyping, FISH, CMA, qPCR, NGS, etc.


Prognosis Assessment
Prognosis Assessment


Servies: Karyotype, Chromosome Variation, Gene Mutation or Rearrangement, etc.

Platforms: Karyotyping, FISH, CMA, qPCR, NGS, etc.


Predictive Biomarkers of Efficacy
Predictive Biomarkers of Efficacy


Servies Target Antigen Positive Cells, etc.

Platforms: Flow, IHC, etc.


Pharmacodynamics Biomarkers
Pharmacodynamics Biomarkers


Servies: Target Gene Mutation or Rearrangement, Target Antigen Positive Cells, etc.

Platforms: FISH, qPCR, NGS, Flow, IHC, etc.


Safety Biomarkers
Safety Biomarkers


Servies: Cytokines and Inflammation-related Markers, etc.

Platforms: LBA, Olink, etc.


Disease Monitoring
Disease Monitoring


Servies: Minimal Residual Disease (MRD) Monitoring, ctDNA, etc.

Platform: Flow, NGS, qPCR, Digital PCR, etc.